Carasent
22.55 SEK
-1.10 %
1,643 following
CARA
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Carasent
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
Dividend yield
Median 2019-2025
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 9.58 | 36.89 | 36.79 | 16.66 | 10.85 | 22.20 | 27.45 |
| Shares | 40.6 | 44.9 | 78.6 | 79.6 | 72.3 | 72.3 | 68.5 |
| Market cap | 389.1 | 1,655.8 | 2,892.5 | 1,326.5 | 784.8 | 1,605.6 | 1,879.5 |
| Enterprise value | 397.4 | 1,499.5 | 2,000.8 | - | - | 1,389.3 | - |
| EV/S | 7.8 | 22.1 | 14.2 | - | - | 5.2 | - |
| EV/EBITDA | 31.6 | 97.3 | 59.0 | - | - | 218.1 | - |
| EV/EBIT | 83.6 | 455.7 | 201.7 | - | - | neg. | - |
| P/E | 114.3 | neg. | 4,418.6 | 40.1 | neg. | neg. | 54.9 |
| P/B | 4.05 | 4.29 | 2.40 | 1.02 | 0.83 | 1.85 | 2.33 |
| P/S | 7.7 | 24.5 | 20.5 | 6.4 | 3.2 | 6.0 | 5.5 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 16.8 % | 0.0 % | 0.0 % |
| Equity ratio | 66.3 % | 79.1 % | 90.0 % | 89.5 % | 87.4 % | 83.3 % | 85.9 % |
| Gearing ratio | 20.7 % | 14.5 % | 1.4 % | 3.0 % | 5.3 % | 4.6 % | 4.0 % |